MENU
VRDN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Viridian Therapeutics (VRDN) Earnings Date & Reports

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

VRDN is expected to report earnings to rise 20.46% to -97 cents per share on May 07

Viridian Therapeutics VRDN Stock Earnings Reports
Q1'25
Est.
$-0.98
Q4'24
Beat
by $0.22
Q3'24
Missed
by $0.09
Q2'24
Missed
by $0.15
Q1'24
Beat
by $0.30
The last earnings report on February 27 showed earnings per share of -81 cents, beating the estimate of -102 cents. With 196.77K shares outstanding, the current market capitalization sits at 1.18B.
View a ticker or compare two or three
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com